{"name":"Iterum Therapeutics, International Limited","slug":"iterum-therapeutics-international-limited","ticker":"","exchange":"","domain":"iteruminternationallimited.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"sulopenem etzadroxil and probenecid","genericName":"sulopenem etzadroxil and probenecid","slug":"sulopenem-etzadroxil-and-probenecid","indication":"Other","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Sulopenem Etzadroxil/Probenecid","genericName":"Sulopenem Etzadroxil/Probenecid","slug":"sulopenem-etzadroxil-probenecid","indication":"Complicated urinary tract infections (cUTIs), including pyelonephritis","status":"phase_3"}]}],"pipeline":[{"name":"sulopenem etzadroxil and probenecid","genericName":"sulopenem etzadroxil and probenecid","slug":"sulopenem-etzadroxil-and-probenecid","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Sulopenem Etzadroxil/Probenecid","genericName":"Sulopenem Etzadroxil/Probenecid","slug":"sulopenem-etzadroxil-probenecid","phase":"phase_3","mechanism":"Sulopenem etzadroxil/probenecid is a combination antibiotic that works by inhibiting bacterial cell wall synthesis and reducing the reabsorption of the antibiotic in the kidneys.","indications":["Complicated urinary tract infections (cUTIs), including pyelonephritis"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-04-01","type":"pipeline","source":"simplywall.st","summary":"Breakeven On The Horizon For Iterum Therapeutics plc (NASDAQ:ITRM) - simplywall.st","headline":"Breakeven On The Horizon For Iterum Therapeutics plc (NASDAQ:ITRM)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOT1hVM2FXcmVFNjFhWFBxUzBVSUx5RkVfS0Fvak11UXppdkU2UTJCc2JtcVlZSEFjWE5GaHBDWGVIUXA0SXAyVlA3YUpFV3pNcmM3V0NsdUJtLWlwRUZqTndUZW9ySE5hYk1GRXFScTh3dHRJby1EdlpCT3ZIc1IwN0gxRHFyZ09RM0FkMDh5dW9fcWUwSHJtMXJkTkM2a1VBdXVrRlk5cVMwdFhuRFJR?oc=5","date":"2026-03-31","type":"pipeline","source":"Fierce Pharma","summary":"Iterum initiates wind-down after failure to offload antibiotic with sluggish sales - Fierce Pharma","headline":"Iterum initiates wind-down after failure to offload antibiotic with sluggish sales","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNZlAxb3RJREVlaVJ0NXVsZUdfOTJrYTlxbm1jSnZQNGVEd0pwTGplYl9aZ0EwQ2lFS0plREl4TlhVVUFsU0ZMQ2E1b0xnOU1zc3lrVzZuSUpMV00wckpnZURvbUlNTjI5RWtYZUprRlotaHlpcWxKTHFBSXVZSmNhU0lIZEVZbG9MQUtSWlZxX0h5cC1JQ3VHSWttcDFNV2tuQURiWU1lTWY5c3A5R0RQQ2pvbVBHbUdi?oc=5","date":"2026-03-31","type":"pipeline","source":"Benzinga","summary":"12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga","headline":"12 Health Care Stocks Moving In Tuesday's After-Market Session","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTFBHR2czSnhZSmtIdjgybVR0c1FNTjJBWmF0b0twLVgzaUQ4cHpPaVliYUptcWNmSUEzQTJhR3ktZlR5T3lmSmNlRllueFZRdnNmNlNmUk40WFZ0dDAzWkHSAWNBVV95cUxQeVJHQ3p0WjAtWHdvbHdLMDdmNXo2aENmYjBzU2xNVTU5RDFFekxRQlhlV3FVM1NqNEdZWmduM0gyZkJPbkVLZXRtbnYyS0FTQWVua1h4b3ZlNUptMGZqYjFEVGM?oc=5","date":"2026-03-27","type":"pipeline","source":"Bitget","summary":"Iterum Therapeutics Plummets 70%: What’s Behind the Freefall in ITRM? - Bitget","headline":"Iterum Therapeutics Plummets 70%: What’s Behind the Freefall in ITRM?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVElHcTNrcFpvT3BrYkNtbUI0WXNDQTdRdEZiVEpHRXFZR19RN0UxOUdNMk5GcURyNnB1U3dFYjZfOTV1anlsa3BxY2xqVE1mOVFCNDhzc3g0dUZMaE1oY09CalBmRTVzRnBua1kxeTNHaHZGNnB6YldQbjdpUW13V0hONVZJblF2YjhJS0ZBQzFVYjltTDU2Y055NHVSTW9Gd1pQQlJ5TDdOWDBmbmtEU3hn?oc=5","date":"2026-03-27","type":"pipeline","source":"Stock Titan","summary":"Iterum Therapeutics (NASDAQ: ITRM) seeks court-backed wind up - Stock Titan","headline":"Iterum Therapeutics (NASDAQ: ITRM) seeks court-backed wind up","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9mRHJqN0s1WERaTldhSHVjcWRVOHFGZzFuMEtoeGJEZzZjNDQwUWZ5ZHBnZ0xyekpHekx5V3dHbXRvVU1CTGIyRTRRSE5xTjRKVG1veXp5SlBlNTNQVzQ5SXJyNkN5aHVRRnV6R1FB?oc=5","date":"2026-03-22","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in Iterum Therapeutics Plc (ITRM) - Stock Titan","headline":"If You Invested $1,000 in Iterum Therapeutics Plc (ITRM)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOSVAtRDJXUFo1eTRnNlhhdHBRRmVPTUcteXVRZktwenhCR1dia0ZhNGdpZlk3X2tpZmQxUU5tUHlIZlVJZ2o4and1SEF0OGhYbGJBTl95WEo0OUR0bW5hVkdjM1pDWFd6bWZTTFV5UjNvZVRDRHBkMEhmOGlzdWYtRDc0ZjRqNUxOcURLRWdqaWpwRmp0ZUpXdm8xLWdfbDRJNjBvMHM0SjNYUXp0cTR0dmRySnJGTUxZT2xF?oc=5","date":"2026-03-11","type":"pipeline","source":"Benzinga","summary":"12 Health Care Stocks Moving In Wednesday's After-Market Session - Acurx Pharmaceuticals (NASDAQ:ACXP), A - Benzinga","headline":"12 Health Care Stocks Moving In Wednesday's After-Market Session - Acurx Pharmaceuticals (NASDAQ:ACXP), A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNN0FQcjdnYjl6Sm01aTV2Y1BWSFdPdnBGWVdxdWF2WUZwbllpVE8yOTVJLVo3LWNwQXdueWRrVFdBdklxRTlRQXE3N1RLSC1jazhUY05ZVXRkbE5hX2hZd0ljSE9RMWJtcE1IdGJzZ2FndzBULWUwMnFWRlJNR2xCSWJpVHZIZlZXd2tGd3VPeDY5T0xZc0ZvaEZHNjBRS1o3UUNOczgtT2I4WUNl?oc=5","date":"2025-11-14","type":"pipeline","source":"BioWorld News","summary":"Invivyd, Emergent and Armata drive infectious disease stock recovery - BioWorld News","headline":"Invivyd, Emergent and Armata drive infectious disease stock recovery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxONWUxQU9PXzdKVXJjTkVDYnVYcjZWeTl5RU5EMWZPS0NCR29ZN3FUcFZmLUczWEloVXB6eGtKWjd5S1B0c21OcnlXLVFlNEFrbm5kQVZlSmpkS1paNndzd0ZhN25jcjJOMnNDQjBuaXo0aURWdW5kNlFXcEowOUZoWXR2TEpzZDZNMERMNG9yZzU1cmpIRXc?oc=5","date":"2025-10-17","type":"pipeline","source":"Yahoo Finance","summary":"Analysts Expect Breakeven For Iterum Therapeutics plc (NASDAQ:ITRM) Before Long - Yahoo Finance","headline":"Analysts Expect Breakeven For Iterum Therapeutics plc (NASDAQ:ITRM) Before Long","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQbjBTTjU3ZUl0YWVOTmhqVDk5cjI3YU1PbndndEZSVkEzVEt6YURJSmdHNnZZTEVjbUU2MkRHVkN6WlA5UEdqSUx3V19kbzJ6Nm43UzUwdVBNYnhkcXFtb3Vqa1ZfbUp6d2tsSFNKdkVEcnZXS2xYQm45OGRxX3hWaHJ2bldrSDJCVHRaQmlZSnB4VlhEOEFtU194akJpTGYwUWZlMU8xbjJhOS1DdjQzLWRiVE1vMzQybVZNdEFHWWw0Zw?oc=5","date":"2025-08-20","type":"pipeline","source":"Fierce Pharma","summary":"Behind Iterum's 'dual-track' strategy to launch nation's first new uncomplicated UTI drug in 25 years - Fierce Pharma","headline":"Behind Iterum's 'dual-track' strategy to launch nation's first new uncomplicated UTI drug in 25 years","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNa1lmTmhkQVRHaklaYVhTZ2lMN3RMdGtjNmVjd24yVTctS3hvS0gzRlVkTGlCSVlCY2ZuRHB4NmFWMDJSMFp1Uk9WTS1YTDhTZXJ2V09CZm9fdl9mcXlwekhDRHJqYkplUXJLbGpXdHVGN2pvci1tZUJHUjVjOFlSYnM1ajVlelU2?oc=5","date":"2025-08-20","type":"pipeline","source":"pharmaphorum","summary":"Iterum brings first oral penem antibiotic to US market - pharmaphorum","headline":"Iterum brings first oral penem antibiotic to US market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOdC1CRmNhQ2VwZGo2OFNaYVpBeERJaDNNUk5wTnZVMUlVUmYwZjN5LWVqcXpUdklqTm9Yb3lWSFllMkVETEpvTVFCY1FjS1lldWVDbkZqb1dJYldodmRrc0VlNmF0R1lvQzgxck4xdjhrVTBNRnlOQzJGZnJYNnQyZVFWZDlPdFc0RGstancwODdISkpoeVlqQXVWbTVhZUZhWEFlUUI5dFZoRUMtV3ljTFp3a1BQdUVsdElubg?oc=5","date":"2025-06-13","type":"deal","source":"pharmaphorum","summary":"EVERSANA expands commercialisation portfolio with OS Therapies and Iterum Therapeutics partnerships - pharmaphorum","headline":"EVERSANA expands commercialisation portfolio with OS Therapies and Iterum Therapeutics partnerships","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":1,"phase_3":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}